1,132
Views
53
CrossRef citations to date
0
Altmetric
Original Articles

Combination of vitamin C, thiamine and hydrocortisone added to standard treatment in the management of sepsis: results from an open label randomised controlled clinical trial and a review of the literature

, , , , , , , & show all
Pages 271-278 | Received 01 Nov 2019, Accepted 13 Jan 2020, Published online: 28 Jan 2020

References

  • Gustot T. Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response. Curr Opin Crit Care. 2011;17(2):153–159.
  • Adhikari NK, Fowler RA, Bhagwanjee S, et al. Critical care and the global burden of critical illness in adults. Lancet. 2010;376(9749):1339–1346.
  • Kaukonen K-M, Bailey M, Suzuki S, et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012. JAMA. 2014;311(13):1308–1316.
  • Dombrovskiy VY, Martin AA, Sunderram J, et al. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007;35(5):1244–1250.
  • Padkin A, Goldfrad C, Brady AR, et al. Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med. 2003;31(9):2332–2338.
  • Pavon A, Binquet C, Kara F, et al. Profile of the risk of death after septic shock in the present era: an epidemiologic study. Crit Care Med. 2013;41(11):2600–2609.
  • Liu V, Escobar GJ, Greene JD, et al. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA. 2014;312(1):90–92.
  • Rangel-Frausto MS, Pittet D, Costigan M, et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 1995;273(2):117–123.
  • Singer M, Deutschman CS, Seymour CW, et al. The Third International consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810.
  • Silva E, Pedro M, Sogayar A, et al. Brazilian sepsis epidemiological study (BASES study). Crit Care. 2004;8(4):R251–R260.
  • Sales JA, David CM, Hatum R. Sepse Brasil: Estudo Epidemiologico da Sepse em Unidades de Terapia Intensiva Brasileiras. An epidemiological study of sepsis in Intensive Care Units. Rev Bras Ter Intensiva. 2006;18:9–17.
  • Todi S, Chatterjee S, Sahu S, et al. Epidemiology of severe sepsis in India: an update. Crit Care. 2010;14(Suppl 1):P382.
  • Marik PE, Khangoora V, Rivera R, et al. Hydrocortisone, Vitamin C and thiamine for the treatment of severe sepsis and septic shock: a retrospective before after study. Chest. 2017;151(6):1229–1238.
  • Balakrishnan M, Gandhi H, Shah K, et al. Hydrocortisone, Vitamin C and thiamine for the treatment of sepsis and septic shock following cardiac surgery. Indian J Anaesth. 2018;62(12):934–939.
  • Shin TG, Kim YJ, Ryoo SM, et al. Early vitamin C and thiamine administration to patients with septic shock in emergency departments: Propensity score-based analysis of a before-and-after cohort study. J Clin Med. 2019;8(1):102.
  • Kim W-Y, Jo E-J, Eom JS, et al. Combined vitamin C, hydrocortisone and thiamine therapy for patients with severe pneumonia who were admitted to the intensive care unit: propensity score based analysis of a before after cohort study. J Crit Care. 2018;47:211–218.
  • Jane JL, Nam Cho H, Bryant N, Moussavi K, et al. Vitamin C, hydrocortisone, and thiamine for the treatment of severe sepsis and septic shock: a retrospective analysis of real-world application. JCM. 2019;8(4):e478.
  • Sadaka F, Grady J, Organti N, et al. Ascorbic acid, thiamine, and steroids in septic shock: propensity matched analysis. J Intensive Care Med. [cited 2019 Jul 17]; [5 p.]. DOI:10.1177/0885066619864541
  • Masood H, Burki AM, Sultan A, et al. Effect of intravenous vitamin C, thiamine, and hydrocortisone (the metabolic resuscitation protocol) on early weaning from vasopressors in patients with septic shock. A descriptive case series study. Cureus. 2019;11(6):e5016.
  • Kellum JA, Lameire N, KDIGO AKI Guideline Work Group. Diagnosis, evaluation and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17(1):204.
  • Perl TM, Dvorak L, Hwang T, et al. Long term survival and function after suspected gram negative sepsis. JAMA. 1995;274(4):338–345.
  • Nesseler N, Defontaine A, Launey Y, et al. Long term mortality and quality of life after septic shock: a follow up observational study. Intensive Care Med. 2013;39(5):881–888.
  • Sasse KC, Nauenberg E, Long A, et al. Long term survival after intensive care unit admission with sepsis. Crit Care Med. 1995;23(6):1040–1047.
  • Prescott HC, Osterholzer JJ, Langa KM, et al. Late mortality after sepsis: propensity matched cohort study. BMJ. 2016;353:i2375.
  • Ou S-M, Chu H, Chao P-W, et al. Long-term mortality and major adverse cardiovascular events in sepsis survivors. A nationwide population-based study. Am J Respir Crit Care Med. 2016;194(2):209–217.
  • Group CS. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358(2):111–124.
  • Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358(9):877–887.
  • Gordon AC, Mason AJ, Thirunavukkarasu N, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316(5):509–518.
  • Woolum JA, Abner EL, Kelly A, et al. Effect of thiamine administration on lactate clearance and mortality in patients with septic shock. Crit Care Med. 2018;46(11):1747–1752.
  • Amrein K, Straaten H, Berger MM. Vitamin therapy in critically ill patients: focus on thiamine, vitamin C, and vitamin D. Intensive Care Med. 2018;44(11):1940–1944.
  • Donnino MW, Andersen LW, Chase M, et al. Randomized, double-blind, placebo-controlled trial of thiamine as a metabolic resuscitator in septic shock: a pilot study. Crit Care Med. 2016;44(2):360–367.
  • Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock. Crit Care Med. 2017;45(3):486–552.
  • Rees DD, Cellek S, Palmer RM, et al. Dexamethasone prevents the induction by endotoxin or a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biophys Res Commun. 1990;173(2):541–547.
  • Yang S, Zhang L. Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol. 2004;2(1):1–12.
  • De Kruif MD, Lemaire LC, Giebelen IA, et al. Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia. J Immunol. 2007;178(3):1845–1851.
  • Siraux V, De Backer D, Yalavatti G, et al. Relative adrenal insufficiency in patients with septic shock: comparison of low-dose and conventional corticotropin tests. Crit Care Med. 2005;33(11):2479–2486.
  • Long C, Maull K, Krishnan R, et al. Ascorbic acid dynamics in the seriously ill and injured. J Surg Res. 2003;109(2):144–148.
  • Carr AC, Shaw GM, Fowler AA, et al. Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock? Crit Care. 2015;19(1):418.
  • Fowler A, Syed A, Knowlson S, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med. 2014;12(1):32.
  • Vitamin C, thiamine and steroids in sepsis (VICTAS). [Accessed 2019 Dec 31]. Available from www.clinicaltrials.gov.
  • The vitamin C, hydrocortisone and thiamine in patients with septic shock trial (VITAMINS). [Accessed 2019 Dec 31]. Available from www.clinicaltrials.gov.
  • Ascorbic acid, corticosteroids, and thiamine in sepsis (ACTS) trial. [Accessed 2019 Dec 31]. Available from www.clinicaltrials.gov.
  • Hydrocortisone, vitamin C, and thiamine for the treatment of sepsis and septic shock (HYVCTTSSS). [Accessed 2019 Dec 31]. Available from www.clinicaltrials.gov.
  • The effect of vitamin C, thiamine and hydrocortisone on clinical course and outcome in patients with severe sepsis and septic shock. [Accessed 2019 Dec 31]. Available from www.clinicaltrials.gov.
  • metabolic resuscitation using ascorbic acid, thiamine, and glucocorticoids in sepsis (ORANGES). [Accessed 2019 Dec 31]. Available from www.clinicaltrials.gov.
  • Evaluation of hydrocortisone, vitamin C and thiamine for the treatment of septic shock (HYVITS). [Accessed 2019 Dec 31]. Available from www.clinicaltrials.goc.
  • Steroids, thiamine, and vitamin C in septic shock (STACSS). [Accessed 2019 Dec 31]. Available from www.clinicaltrials.gov.
  • Thiamine, vitamin C and hydrocortisone in the treatment of septic shock. [Accessed 2019 Dec 31]. Available from www.clinicaltrials.gov.
  • ATESS Trial. [Accessed 2019 Dec 31]. Available from www.clinicaltrials.gov.in.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.